https://charts.traderzeitung.de/phases/US0070022076 string(1415) "{"isin":"US0070022076","name":"Adicet Bio Inc","stock_id_xnas":132475215,"stock_id_xnys":132475216,"generated_at":"2026-09-24 01:32:00","days":[{"date":"2026-09-21","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":8.96,"close_at":"2026-09-21 21:23:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-22","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":9.21,"close_at":"2026-09-22 21:52:00","complete":true,"perf_pct":2.7902},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-09-23","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":8.46,"close_at":"2026-09-23 21:59:00","complete":true,"perf_pct":-8.1433},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":8.63,"close_at":"2026-09-24 00:43:00","complete":false,"perf_pct":2.0095}]}]}"

Adicet Bio Aktie News & Nachrichten

[WKN: A41X5V | Symbol: ACET]

Realtimekurs

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

10J

Alles

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

Artikel aus der Redaktion der Trader-Zeitung

Es konnten keine Nachrichten über Adicet Bio gefunden werden.

Adicet Bio Nachrichtenticker öffnen

MT Newswires 27.08.2026 23:01 Uhr

Adicet Bio erhält FDA-Zulassung für IND von ADI-212 bei Prostatakrebs

05:00 PM EDT, 27.08.2026 (MT Newswires) -- Adicet Bio Inc (ACET) teilte am Donnerstag mit, dass die US-amerikanische Arzneimittelbehörde FDA den Antra